Effector and suppressor roles for LFA-1 during the development of experimental autoimmune encephalomyelitis
- 1 January 2009
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 206 (1-2) , 22-27
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Getting to the site of inflammation: the leukocyte adhesion cascade updatedNature Reviews Immunology, 2007
- The role of the integrin LFA‐1 in T‐lymphocyte migrationImmunological Reviews, 2007
- p150/95 (CD11c/CD18) Expression Is Required for the Development of Experimental Autoimmune EncephalomyelitisThe American Journal of Pathology, 2007
- A critical role of LFA-1 in the development of Th17 cells and induction of experimental autoimmune encephalomyelytisBiochemical and Biophysical Research Communications, 2007
- Molecular mechanisms involved in T cell migration across the blood–brain barrierJournal of Neural Transmission, 2006
- Immune cell migration in inflammation: present and future therapeutic targetsNature Immunology, 2005
- IMMUNOLOGY OF MULTIPLE SCLEROSISAnnual Review of Immunology, 2005
- Novel biologic therapies for psoriasisExpert Opinion on Biological Therapy, 2004
- T Cell Response in Experimental Autoimmune Encephalomyelitis (EAE): Role of Self and Cross-Reactive Antigens in Shaping, Tuning, and Regulating the Autopathogenic T Cell RepertoireAnnual Review of Immunology, 2002
- Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrinNature, 1992